SCHEMBL97129

SCHEMBL97129

O=[C]CCC=CCCc1cccc2c1OCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.38
MTNR1A P48039 6/20 0.37
EED O75530 2/20 0.36
GSK3B P49841 1/20 0.35
FAAH O00519 1/20 0.34
HTR2A P28223 2/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
TSHR P16473 3/20 0.34
MAPK1 P28482 3/20 0.34
HSD17B10 Q99714 3/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTR2C P28335 1/20 0.33
MAOB P27338 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.32
ALOX15 P16050 2/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL97128 1.00 KDM4C (0.38) KDM4CMTNR1AEEDGSK3BFAAH
SCHEMBL3243511 0.82 MTNR1A (0.45) KDM4CMTNR1AEEDGSK3BFAAH
SCHEMBL11753378 0.79 KDM4C (0.43) KDM4CMTNR1AEEDGSK3BFAAH
SCHEMBL11196197 0.75 EED (0.43) KDM4CMTNR1AEEDGSK3BFAAH
SCHEMBL96450 0.73 MAOB (0.41) KDM4CEEDGSK3BALDH1A1HPGD
SCHEMBL96451 0.73 MAOB (0.41) KDM4CEEDGSK3BALDH1A1HPGD
SCHEMBL7771835 0.73 KDM4C (0.46) KDM4CMTNR1AEEDGSK3BFAAH
SCHEMBL1010010 0.73 TAAR1 (0.46) KDM4CMTNR1AEEDHTR2AHTR2C
SCHEMBL1145518 0.72 EED (0.46) KDM4CMTNR1AEEDGSK3BFAAH
SCHEMBL7269544 0.72 HTR2A (0.43) KDM4CMTNR1AEEDFAAHHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB KDM4C 1847/4885MTNR1A 1110/4885EED 4310/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 KDM4C 4207/4885MTNR1A 460/4885EED 4090/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 KDM4C 4207/4885MTNR1A 460/4885EED 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.